Prevention

A new study from investigators at Drexel University revealed that if 25% of high-risk men who have sex with men appropriately used the pre-exposure prophylaxis (PrEP), 3 out of every 10 HIV infections in this population could be prevented.

By making this information available the FDA hopes to help improve patient outcomes, better manage antibiotic use, and decrease antimicrobial resistance.

As new flu deaths are reported throughout the United States, a pair of studies highlights some of the strengths and weaknesses of the flu shot.

Could forcing pathogens to compete for resources be the key to fighting drug-resistance and extending the lives of existing drugs?

William Schaffner, MD, shares stories to motivate patients and health care providers to receive the flu vaccine.

Five outbreaks of hepatitis A continue to beat down on several states; can addressing the homelessness crisis prevent future outbreaks from happening?

Predicting the next infectious disease outbreak may be possible by analyzing trends on Twitter and Google.

Does following the NSQIP reduce post-operative UTIs?

Researchers have developed a new material for use in dental procedures that uses an antimicrobial agent to fight off bacteria and prevent plaque buildup.

Richard Haupt, MD, MPH, explains how Pfizer is addressing the need for a C. difficile vaccine.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

A pair of studies recently conducted as part of the Human Vaccines Project are giving new insight into the human immune system and how researchers can develop better vaccines.

Edmond Hooker, MD, DrPH, discusses how many people have fallen ill or even died due to contaminated hospital mattresses.

Here are a few things your friendly infection control team would appreciate for the holidays.

The US Food and Drug Administration (FDA) has approved a rapid diagnostic test for Valley Fever.

Following a severe flu season in the Southern Hemisphere and mounting research that egg-based flu vaccines don’t offer enough protection, experts are warning that the Northern Hemisphere may be in for a tough flu season.

We break down the Top 5 infectious disease news reported by Contagion® for the month of November 2017.

The results of 3 phase 1 clinical trials have shown that an investigational Zika purified inactivated virus vaccine was well-tolerated and induced an immune response in adult participants.

William Schaffner, MD, addresses common misconceptions regarding the influenza vaccine.

This approach could significantly cut down on the cost and time needed to develop new antibiotics, which is critical considering the current antibiotic landscape.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Edmond Hooker, MD, DrPH, discusses the reasons behind why hospital rooms are not being disinfected properly.

The National Institutes of Health (NIH) have announced plans for a new trial testing the effectiveness of the injectable pre-exposure prophylaxis (PrEP) drug, cabotegravir, in sexually-active women.

Researchers on a new study have added more unwanted effects to the list of side effects from these life-saving drugs, further supporting the call for appropriate antibiotic use.

Individuals with cancer and HIV used to be excluded from clinical trials due to safety concerns, but new positive results open up treatment avenues for this population.